![Shaun Francis Grady](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Shaun Francis Grady
Vorsitzender bei Cambridge United Football Club Ltd.
Profil
Shaun Francis Grady is currently the Chairman of Cambridge United Football Club Ltd.
He is also a Director at The Cambridge Arts Theatre Trust Ltd.
and Healx Ltd.
Previously, he was a Director at MedImmune LLC in 2007 and held the position of VP-Strategic Partnering & Business Development at AstraZeneca PLC.
Aktive Positionen von Shaun Francis Grady
Unternehmen | Position | Beginn |
---|---|---|
The Cambridge Arts Theatre Trust Ltd.
![]() The Cambridge Arts Theatre Trust Ltd. Movies/EntertainmentConsumer Services The Cambridge Arts Theatre Trust Ltd. operates as a theatre that presents a varied mix of drama, dance, opera and pantomime. The company was founded on March 27, 1998 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 09.02.2016 |
Healx Ltd.
![]() Healx Ltd. BiotechnologyHealth Technology Healx Ltd. engages in the development of a platform that enables treatment predictions for rare diseases. It offers HealNet, an artificial intelligence platform for rare diseases. Its solutions include orphan disease strategy, indication expansion, combination therapies, and shelved assets. The company was founded by Tim Guilliams and David Ryall Brownn and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Cambridge United Football Club Ltd.
![]() Cambridge United Football Club Ltd. Movies/EntertainmentConsumer Services Cambridge United Football Club Ltd. operates as a professional football club. The company is headquartered in Cambridge, the United Kingdom. | Vorsitzender | - |
Ehemalige bekannte Positionen von Shaun Francis Grady
Unternehmen | Position | Ende |
---|---|---|
MedImmune LLC
![]() MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Direktor/Vorstandsmitglied | 21.06.2007 |
ASTRAZENECA PLC | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ASTRAZENECA PLC | Health Technology |
Private Unternehmen | 4 |
---|---|
MedImmune LLC
![]() MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Cambridge United Football Club Ltd.
![]() Cambridge United Football Club Ltd. Movies/EntertainmentConsumer Services Cambridge United Football Club Ltd. operates as a professional football club. The company is headquartered in Cambridge, the United Kingdom. | Consumer Services |
The Cambridge Arts Theatre Trust Ltd.
![]() The Cambridge Arts Theatre Trust Ltd. Movies/EntertainmentConsumer Services The Cambridge Arts Theatre Trust Ltd. operates as a theatre that presents a varied mix of drama, dance, opera and pantomime. The company was founded on March 27, 1998 and is headquartered in Cambridge, the United Kingdom. | Consumer Services |
Healx Ltd.
![]() Healx Ltd. BiotechnologyHealth Technology Healx Ltd. engages in the development of a platform that enables treatment predictions for rare diseases. It offers HealNet, an artificial intelligence platform for rare diseases. Its solutions include orphan disease strategy, indication expansion, combination therapies, and shelved assets. The company was founded by Tim Guilliams and David Ryall Brownn and is headquartered in Cambridge, the United Kingdom. | Health Technology |